Galactosyltransferase 4 is a major control point for glycan branching in N-linked glycosylation

ABSTRACT Protein N-glycosylation is a common post-translational modification that produces a complex array of branched glycan structures. The levels of branching, or antennarity, give rise to differential biological activities for single glycoproteins. However, the precise mechanism controlling the glycan branching and glycosylation network is unknown. Here, we constructed quantitative mathematical models of N-linked glycosylation that predicted new control points for glycan branching. Galactosyltransferase, which acts on N-acetylglucosamine residues, was unexpectedly found to control metabolic flux through the glycosylation pathway and the level of final antennarity of nascent protein produced in the Golgi network. To further investigate the biological consequences of glycan branching in nascent proteins, we glycoengineered a series of mammalian cells overexpressing human chorionic gonadotropin (hCG). We identified a mechanism in which galactosyltransferase 4 isoform regulated N-glycan branching on the nascent protein, subsequently controlling biological activity in an in vivo model of hCG activity. We found that galactosyltransferase 4 is a major control point for glycan branching decisions taken in the Golgi of the cell, which might ultimately control the biological activity of nascent glycoprotein.

[1]  Pamela Stanley,et al.  Chinese Hamster Ovary (CHO) Cells May Express Six β4-Galactosyltransferases (β4GalTs) , 2001, The Journal of Biological Chemistry.

[2]  Kai Griebenow,et al.  Effects of glycosylation on the stability of protein pharmaceuticals. , 2009, Journal of pharmaceutical sciences.

[3]  Armin Ruf,et al.  Unique carbohydrate–carbohydrate interactions are required for high affinity binding between FcγRIII and antibodies lacking core fucose , 2011, Proceedings of the National Academy of Sciences.

[4]  J. Ravetch,et al.  Anti-Inflammatory Activity of Immunoglobulin G Resulting from Fc Sialylation , 2006, Science.

[5]  J. Egrie,et al.  Darbepoetin alfa has a longer circulating half-life and greater in vivo potency than recombinant human erythropoietin. , 2003, Experimental hematology.

[6]  Ionel Ciucanu,et al.  A simple and rapid method for the permethylation of carbohydrates , 1984 .

[7]  B. van den Hazel,et al.  Glycosylation of an N-terminal extension prolongs the half-life and increases the in vivo activity of follicle stimulating hormone. , 2003, The Journal of clinical endocrinology and metabolism.

[8]  Kelvin H. Lee,et al.  The genomic sequence of the Chinese hamster ovary (CHO)-K1 cell line , 2011, Nature Biotechnology.

[9]  P. Umaña,et al.  The carbohydrate at FcgammaRIIIa Asn-162. An element required for high affinity binding to non-fucosylated IgG glycoforms. , 2006, The Journal of biological chemistry.

[10]  J. Dennis,et al.  Complex N-Glycan Number and Degree of Branching Cooperate to Regulate Cell Proliferation and Differentiation , 2007, Cell.

[11]  P. Stanley,et al.  Chinese hamster ovary (CHO) cells may express six beta 4-galactosyltransferases (beta 4GalTs). Consequences of the loss of functional beta 4GalT-1, beta 4GalT-6, or both in CHO glycosylation mutants. , 2001, Journal of Biological Chemistry.

[12]  N. Sharon,et al.  Protein glycosylation. Structural and functional aspects. , 1993, European journal of biochemistry.

[13]  O. P. Bahl,et al.  Structures of N-glycosidic carbohydrate units of human chorionic gonadotropin. , 1979, The Journal of biological chemistry.

[14]  R. Dwek,et al.  Glycosylation changes of IgG associated with rheumatooid arthritis can activate complement via the mannose-binding protein , 1995, Nature Medicine.

[15]  P. Robbins,et al.  alpha-D-Mannosidases of rat liver Golgi membranes. Mannosidase II is the GlcNAcMAN5-cleaving enzyme in glycoprotein biosynthesis and mannosidases Ia and IB are the enzymes converting Man9 precursors to Man5 intermediates. , 1982, The Journal of biological chemistry.

[16]  Meir Shinitzky,et al.  Structural and functional aspects , 1994 .

[17]  P. Stanley,et al.  Glycomics Profiling of Chinese Hamster Ovary Cell Glycosylation Mutants Reveals N-Glycans of a Novel Size and Complexity* , 2009, The Journal of Biological Chemistry.

[18]  James E. Bailey,et al.  Engineered glycoforms of an antineuroblastoma IgG1 with optimized antibody-dependent cellular cytotoxic activity , 1999, Nature Biotechnology.

[19]  M. Takeuchi,et al.  Remodeling of sugar chain structures of human interferon-gamma. , 2000, Glycobiology.

[20]  Y. Ikeda,et al.  UDP-GlcNAc concentration is an important factor in the biosynthesis of beta1,6-branched oligosaccharides: regulation based on the kinetic properties of N-acetylglucosaminyltransferase V. , 2002, Glycobiology.

[21]  T. Baranski,et al.  Generation of a lysosomal enzyme targeting signal in the secretory protein pepsinogen , 1990, Cell.

[22]  G. Warren,et al.  A model for the retention of Golgi enzymes , 1993 .

[23]  J. Marth,et al.  A genetic approach to Mammalian glycan function. , 2003, Annual review of biochemistry.

[24]  G. Weißhaar,et al.  Site-specific N-glycosylation of human chorionic gonadotrophin--structural analysis of glycopeptides by one- and two-dimensional 1H NMR spectroscopy. , 1991, Glycobiology.

[25]  S. Kellokumpu,et al.  Golgi N-Glycosyltransferases Form Both Homo- and Heterodimeric Enzyme Complexes in Live Cells* , 2010, The Journal of Biological Chemistry.

[26]  Andrew G McDonald,et al.  GlycoForm and Glycologue: two software applications for the rapid construction and display of N-glycans from mammalian sources , 2010, BMC Research Notes.

[27]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[28]  K. Shitara,et al.  The Absence of Fucose but Not the Presence of Galactose or Bisecting N-Acetylglucosamine of Human IgG1 Complex-type Oligosaccharides Shows the Critical Role of Enhancing Antibody-dependent Cellular Cytotoxicity* , 2003, The Journal of Biological Chemistry.

[29]  P. Stanley,et al.  Molecular analysis of three gain-of-function CHO mutants that add the bisecting GlcNAc to N-glycans. , 2004, Glycobiology.

[30]  Kouhei Tsumoto,et al.  Fucose depletion from human IgG1 oligosaccharide enhances binding enthalpy and association rate between IgG1 and FcgammaRIIIa. , 2004, Journal of molecular biology.

[31]  Raymond A. Dwek,et al.  Emerging Principles for the Therapeutic Exploitation of Glycosylation , 2014, Science.

[32]  S. Iida,et al.  Nonfucosylated Therapeutic IgG1 Antibody Can Evade the Inhibitory Effect of Serum Immunoglobulin G on Antibody-Dependent Cellular Cytotoxicity through its High Binding to FcγRIIIa , 2006, Clinical Cancer Research.

[33]  L. Presta,et al.  Lack of Fucose on Human IgG1 N-Linked Oligosaccharide Improves Binding to Human FcγRIII and Antibody-dependent Cellular Toxicity* , 2002, The Journal of Biological Chemistry.

[34]  P. Robbins,et al.  Transporters of nucleotide sugars, ATP, and nucleotide sulfate in the endoplasmic reticulum and Golgi apparatus. , 1998, Annual review of biochemistry.

[35]  P. Stanley.  A Method to the Madness of N-Glycan Complexity? , 2007, Cell.

[36]  S. Fujimoto,et al.  Glycosylation and Placental Transport of Immunoglobulin G , 1996 .

[37]  T Nilsson,et al.  Mapping the distribution of Golgi enzymes involved in the construction of complex oligosaccharides. , 1995, Journal of cell science.

[38]  P. Stanley.  Chinese hamster ovary cell mutants with multiple glycosylation defects for production of glycoproteins with minimal carbohydrate heterogeneity , 1989, Molecular and cellular biology.

[39]  H. Schachter.  Biosynthetic controls that determine the branching and microheterogeneity of protein-bound oligosaccharides. , 1986, Advances in experimental medicine and biology.

[40]  S. Elliott,et al.  Glycoengineering: the effect of glycosylation on the properties of therapeutic proteins. , 2005, Journal of pharmaceutical sciences.

[41]  O Hindsgaul,et al.  Regulation of I-Branched Poly-N-Acetyllactosamine Synthesis , 1999, The Journal of Biological Chemistry.

[42]  A. Morell,et al.  The dual role of sialic acid in the hepatic recognition and catabolism of serum glycoproteins. , 1974, Biochemical Society symposium.

[43]  Wei-Shou Hu,et al.  Systems Analysis of N-Glycan Processing in Mammalian Cells , 2007, PloS one.

[44]  Roy Jefferis,et al.  Glycosylation as a strategy to improve antibody-based therapeutics , 2009, Nature Reviews Drug Discovery.

[45]  David J. Harvey,et al.  HPLC-based analysis of serum N-glycans on a 96-well plate platform with dedicated database software. , 2008, Analytical biochemistry.

[46]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[47]  H. Katinger,et al.  Biochemical characterization of rhEpo-Fc fusion protein expressed in CHO cells. , 2006, Protein expression and purification.

[48]  M. Betenbaugh,et al.  A mathematical model of N-linked glycosylation. , 2005, Biotechnology and bioengineering.

[49]  J E Bailey,et al.  A mathematical model of N-linked glycoform biosynthesis. , 1997, Biotechnology and bioengineering.

[50]  M. Moscarello,et al.  Branch specificity of purified rat liver Golgi UDP-galactose: N-acetylglucosamine beta-1,4-galactosyltransferase. Preferential transfer of of galactose on the GlcNAc beta 1,2-Man alpha 1,3-branch of a complex biantennary Asn-linked oligosaccharide. , 1984, The Journal of biological chemistry.

[51]  Pauline M Rudd,et al.  Detailed structural analysis of N-glycans released from glycoproteins in SDS-PAGE gel bands using HPLC combined with exoglycosidase array digestions. , 2006, Methods in molecular biology.